June 24, 2020

CHDI Launches 5-Year State and National Initiative to Improve Trauma Screening to Better Identify Youth

June 24, 2020/ Bernard Kavaler

The Connecticut-based Child Health and Development Institute (CHDI) is launching a five-year initiative to improve child trauma screening in Connecticut and nationwide. The initiative, Trauma ScreenTIME (Screen, Triage, Inform, Mitigate, Engage), will develop online staff training for child-serving professionals to improve early identification and support of children suffering from traumatic stress and connection to evidence-based treatment.

June 16, 2020

Racism is a Public Health Emergency: State Senator Urges CT to be 1st State to Issue Declaration

June 16, 2020/ Bernard Kavaler

“Racism is absolutely a public health issue and a threat to health,” said Patricia Baker, president and CEO of the Connecticut Health Foundation. “Racism is an underlying cause of the many racial and ethnic health disparities that exist in Connecticut.” State Senator Saud Anwar is urging Gov. Lamont to declare racism as a public health emergency, citing data that makes the case. CT would be the first state to do so.

June 12, 2020

The Return of Plastic Bottle Recycling in Connecticut Ahead of Other States

June 12, 2020/ Bernard Kavaler

Connecticut became the first state in the U.S. to re-start container deposit programs after suspending operations upon the arrival of the coronavirus pandemic in mid-March. Container deposit programs got underway in mid-May to solid reviews, following their COVID-19 downtime.

June 02, 2020

American Heart Association First-Ever Statement on Children’s Healthy Eating Supports UConn Center Research

June 02, 2020/ Bernard Kavaler

How children are fed may be just as important as what they are fed, according to a new scientific statement from the American Heart Association. The formal statement is the first ever from the Association focused on providing evidence-based strategies for parents and caregivers to create a healthy food environment for young children, and very much in line with ongoing research by the Rudd Center at UConn.

May 26, 2020

Dementia Gene Raises Risk of Severe COVID-19; UConn Health Researcher Analyzes Potential Groundbreaking Data

May 26, 2020/ Bernard Kavaler

Having a specific gene, which previous genetic studies have found to be linked to dementia, doubles the risk of developing severe COVID-19, according to a newly published large-scale study with data analysis led by a University of Connecticut researcher.

May 19, 2020

New CEO Named at Connecticut Health Foundation, Cites Current Crisis as Evidence of Progress Yet to be Achieved

May 19, 2020/ Bernard Kavaler

Tiffany Donelson is named as the next president and CEO of the Connecticut Health Foundation, at a time when the challenges facing the state’s largest foundation dedicated to health equity for people of color has become even more apparent during the COVID-19 crisis.

May 17, 2020

Connecticut’s Thriving Co-working Spaces Make Revisions for New Normal

May 17, 2020/ Bernard Kavaler

he number and variety of locations had been steadily growing across Connecticut, and now, after weeks of stay-at-home orders, co-working spaces are making adjustments to prepare for members and visitors to return. The goal of building a community within co-working locations remains, but day-to-day routines are being altered for safety and peace of mind.

May 10, 2020

Individuals with Rare Diseases Impacted, Concerned by COVID-19

May 10, 2020/ Bernard Kavaler

The findings of a COVID-19 Community Survey Report conducted by the National Organization for Rare Disorders (NORD) reveals the far-reaching impact the pandemic is having on patients and families with rare disorders.

April 29, 2020

UConn Spin-off ImStem Biotechnology to Move Forward with Clinical Trial of Investigational New Drug for Treatment of Multiple Sclerosis

April 29, 2020/ Bernard Kavaler

Just as the United States was recognizing the severity of the coronavirus and state governments were reacting to the impending health crisis, a Farmington-based company with ties to the University of Connecticut that has been pursuing a cure for another elusive disease received milestone news from the U.S. Food and Drug Administration (FDA).